Corneal cross-linking has been approved to treat keratoconus. Specifically, the Photrexa Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) 0.146%, Photrexa (riboflavin 5’-phosphate ophthalmic solution) 0.146%, and the KXL system were the modality that was approved. This procedure has been used …
The LEDs used in our digital devices emit light that is shifted toward the blue spectrum. Recent experimental as well as observational studies have shown that intense or sustained blue light exposure can cause retinal damage in animals. In response …
Figuring out why people become nearsighted (myopic), and how to keep them from becoming more so, has been a goal of eye doctors for some time now. Over the years, we’ve tried a wide variety of strategies such as having …